Announcements

Lung Cancer and COVID-19 in the Outpatient Setting: What Clinicians Need to Know

Course Type: Live CME/CE Webinar 
Number of Credits: 1
Credit Type: 
CME/CE-certified, MOC-eligible

DATES AND TIMES
Tuesday, September 15, 2020 
4:00 – 5:00 PM ET

(8:00 – 9:00 PM GMT / 3:00 – 4:00 PM CT / 1:00 – 2:00 PM PT)

Tuesday, September 29, 2020
1:00 – 2:00 PM ET

(5:00 – 6:00 PM GMT / 12:00 Noon – 1:00 PM CT / 10:00 – 11:00 AM PT)

Thursday, October 15, 2020
7:00 – 8:00 PM ET
(11:00 PM – 12:00 AM GMT / 6:00 – 7:00 PM CT / 4:00 – 5:00 PM PT)
 
Patients with underlying health conditions such as lung cancer are at greater risk for infection or complications from COVID-19. Because of this increased risk, it is important that these patients are carefully managed, with telemedicine replacing in-person visits where possible. However, monitoring patients via telemedicine requires special attention, particularly because symptoms of COVID-19 infection are similar to common adverse events associated with lung cancer treatment.

This activity, “Lung Cancer and COVID-19 in the Outpatient Setting: What Clinicians Need to Know” will provide clinicians with the most up-to-date guidance on managing lung cancer during the current pandemic, including information on the pathophysiology of Sars-Cov-2, the risk of infection in patients with lung cancer, and strategies to manage patient care and counsel through telemedicine.
Some topics covered:
  • The Pathophysiology of COVID-19
  • Patient and Disease Features that Increase Risk of COVID-19 Infection and Complications in Patients with Lung Cancer
  • Recommendations for Managing Patients with Lung Cancer in the COVID-19 Pandemic
FACULTY:

Sandra Cuellar, PharmD, BCOP
Associate Professor
University of Illinois at Chicago College of Pharmacy
Clinical Oncology Pharmacist, UI Health
Chicago, IL 

J. Morgan Freiman, MD, MSc
Infectious Diseases Physician
Director of Antimicrobial Stewardship
Lahey Hospital and Medical Center
Assistant Professor of Medicine
Tufts University School of Medicine
Boston, MA

Antonio Passaro, MD, PhD
Division of Thoracic Oncology
European Institute of Oncology
Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS)
Milan, Italy

Beth Sandy, CRNP
Medical Oncology
Penn Medicine
Philadelphia, PA

CLICK HERE FOR ACCREDITATION INFORMATION, AND TO REGISTER:

Tuesday, September 29, 2020
1:00 – 2:00 PM ET

(5:00 – 6:00 PM GMT / 12:00 Noon – 1:00 PM CT / 10:00 – 11:00 AM PT)

Thursday, October 15, 2020
7:00 – 8:00 PM ET
(11:00 PM – 12:00 AM GMT / 6:00 – 7:00 PM CT / 4:00 – 5:00 PM PT)
 
Patients with underlying health conditions such as lung cancer are at greater risk for infection or complications from COVID-19. Because of this increased risk, it is important that these patients are carefully managed, with telemedicine replacing in-person visits where possible. However, monitoring patients via telemedicine requires special attention, particularly because symptoms of COVID-19 infection are similar to common adverse events associated with lung cancer treatment.

This activity, “Lung Cancer and COVID-19 in the Outpatient Setting: What Clinicians Need to Know” will provide clinicians with the most up-to-date guidance on managing lung cancer during the current pandemic, including information on the pathophysiology of Sars-Cov-2, the risk of infection in patients with lung cancer, and strategies to manage patient care and counsel through telemedicine.
Some topics covered:
  • The Pathophysiology of COVID-19
  • Patient and Disease Features that Increase Risk of COVID-19 Infection and Complications in Patients with Lung Cancer
  • Recommendations for Managing Patients with Lung Cancer in the COVID-19 Pandemic

FACULTY:

Sandra Cuellar, PharmD, BCOP
Associate Professor
University of Illinois at Chicago College of Pharmacy
Clinical Oncology Pharmacist, UI Health
Chicago, IL 

J. Morgan Freiman, MD, MSc
Infectious Diseases Physician
Director of Antimicrobial Stewardship
Lahey Hospital and Medical Center
Assistant Professor of Medicine
Tufts University School of Medicine
Boston, MA

Antonio Passaro, MD, PhD
Division of Thoracic Oncology
European Institute of Oncology
Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS)
Milan, Italy

Beth Sandy, CRNP
Medical Oncology
Penn Medicine
Philadelphia, PA


CLICK HERE FOR ACCREDITATION INFORMATION, AND TO REGISTER:

------

Three filing cainets, free. Please call: (201) 486-3317


​-----

P
ursuant to law, New Jersey controlled dangerous substances (CDS) registrants are required to register with the New Jersey Prescription Monitoring Program (NJPMP). To date, approximately 2,500 New Jersey CDS Physicians have been identified as non-compliant with the NJPMP registration requirement. As a result, the CDS registration for said physicians has been placed in “active non-renewable” (ANR) status and they will be unable to renew their CDS during the October 2020 renewal period until they’ve successfully registered with the NJPMP.
 
In the coming weeks, a detailed notice will be emailed to those CDS Physicians placed in ANR status advising them of the status of their CDS and the NJPMP registration requirement and instruct them to immediately register with the NJPMP.
 
No action is required by CDS physicians who already have an active NJPMP account.
 
CDS Physicians who are not registered with the NJPMP must:
 
STEP 1: Register to access the NJPMP
Immediately register at https://newjersey.pmpaware.net/. Registrants will be required to enter his/her full professional license number; federal Drug Enforcement Administration (DEA) number; NJ CDS registration number; full name as it appears on his/her professional license; unique email address; and other identifying information.
 
STEP 2: Notify the Drug Control Unit
Once the physician has registered to access the NJPMP, he/she should notify the New Jersey Drug Control Unit via email at CDS@dca.lps.state.nj.us.
 
STEP 3: Permission to renew CDS registration
Following verification of the Physicians NJPMP registration, the status of his/her CDS registration will be updated to “active” and he/she will receive an email permitting him/her to renew his/her CDS during the October 2020 renewal period.
 
Physicians with an active CDS registration that do not prescribe controlled dangerous substances or do not currently hold a New Jersey DEA registration, in accordance with N.J.A.C.13:45H-1.2(m), must email the New Jersey Drug Control Unit to place his/her CDS registration in “inactive” status.
 
Drug Control Unit
P.O. Box 45045
Newark, NJ 07101
Phone: (973) 504-6351
Fax: (973) 504-6326
Registration Verification: (973) 273-8090

-------

Guidance for COVID-19 Diagnosed and/or Exposed Healthcare Personnel

-------
Quick Reference: Discontinuation of Transmission-Based Precautions and Home Isolation for Persons Diagnosed with COVID-19

-------

Morris County Testing Sites (updated 6/22/20)

-------

IMPORTANT COVID19 UPDATE

Morris County will be discontinuing COVID-19 testing at County College of Morris (CCM) on Friday, June 26, 2020. In addition, no testing will be offered on Tuesday, June 23, 2020 due to a scheduled event at the CCM. 

​The County commenced operation of the test site on March 30th and has tested over 7,000 individuals. The decision to discontinue operations is due to less than 1% of persons testing positive over the last couple of weeks and greater availability of RT-PCR testing at pharmacies and urgent care centers.

-------

State of New Jersey Department of Health: Re: Guidance for providers and facilities performing COVID-19 testing

-------

The Department of Health and Human Services (HHS) has posted new Frequently Asked Questions regarding the second tranche of disbursement of the CARES Act Provider Relief Fund. Please note there is conflicting information about whether a provider who hasn’t previously received money from the first round of funding can apply for this round. The AMA is trying to clarify this and other questions with HHS.

-------
Executive Order 109 requires physician practices to report inventory of Personal Protective Equipment and other medical resources to the Office of Emergency Management.
Please click here to report this information online by 5:00pm today, Friday, March 27.

-------

American Medical Association: A physician’s guide to COVID-19

-------

MSNJ Annual Meeting

The Medical Society of New Jersey Annual Meeting which was scheduled for May 1 – 2, 2020 has been canceled. More details on the Annual Meeting will be forthcoming.

-------
 
COVID 19 Update

Centers for Disease Control and Prevention:“CDC”
World Health Organization (“WHO”)
New Jersey Department of Health
-------

Understanding and Addressing the Global Spread of the COVID-19 Infection: A Clinician’s Guide

-------

CORONAVIRUS DISEASE 2019 (COVID 19) Flyer

-------

The Centers for Disease Control and Prevention (CDC) is closely monitoring an outbreak of respiratory illness caused by a novel (new) coronavirus first identified in Wuhan, Hubei Province, China. Please review the following resources for situational awareness and infection prevention support: